Who
Lisa Walters-Hoffert
Director
Company insider
Files Form 4 as: Director, Kiora Pharmaceuticals; Director, Flux Power Holdings; Chief Financial Officer, Dare Bioscience.
In numbers
- Trades disclosed
- 43
- Buys
- 2
- Sells
- 4
- Bought
- $11K
- Sold
- $76K
- Companies
- 3
- Companies where not an officer
- 2
- First trade
- 19 Jul 2017
- Last trade
- 10 Jun 2026
- Last filed
- 12 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 10 Jun 2026filed 12 Jun 2026 | KPRX Kiora Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 10 Jun 2026filed 12 Jun 2026 | KPRX Kiora Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 28 May 2026filed 1 Jun 2026 | FLUX Flux Power HoldingsElectronic Components & EMS | SEC FORM 4 Code M | —50,000 | filing |
| 28 May 2026filed 1 Jun 2026 | FLUX Flux Power Holdingsoption or derivative · Electronic Components & EMS | SEC FORM 4 Code M | —50,000 | filing |
| 28 May 2026filed 1 Jun 2026 | FLUX Flux Power Holdingsoption or derivative · Electronic Components & EMS | SEC FORM 4 Code M | —50,000 | filing |
| 28 May 2026filed 1 Jun 2026 | FLUX Flux Power HoldingsElectronic Components & EMS | SEC FORM 4 Code M | —50,000 | filing |
| 28 May 2025filed 1 Jun 2026 | FLUX Flux Power Holdingsoption or derivative · Electronic Components & EMS | SEC FORM 4 Code A | —50,000 | filing |
| 28 May 2025filed 1 Jun 2026 | FLUX Flux Power Holdingsoption or derivative · Electronic Components & EMS | SEC FORM 4 Code A | —50,000 | filing |
| 18 Apr 2025filed 21 Apr 2025 | FLUX Flux Power Holdingsoption or derivative · Electronic Components & EMS | SEC FORM 4 Code M | —17,057 | filing |
| 18 Apr 2025filed 21 Apr 2025 | FLUX Flux Power HoldingsElectronic Components & EMS | SEC FORM 4 Code M | —17,057 | filing |
| 1 Apr 2025filed 2 Apr 2025 | KPRX Kiora Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 19 Aug 2024filed 20 Aug 2024 | KPRX Kiora PharmaceuticalsBiotechnology | SEC FORM 4 Bought | $4,8251,250 at $3.86 | filing |
| 1 Jul 2024filed 3 Jul 2024 | KPRX Kiora Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,778 at $0.00 | filing |
| 29 Apr 2024filed 30 Apr 2024 | FLUX Flux Power Holdingsoption or derivative · Electronic Components & EMS | SEC FORM 4 Code M | —1,526 | filing |
| 29 Apr 2024filed 30 Apr 2024 | FLUX Flux Power HoldingsElectronic Components & EMS | SEC FORM 4 Code M | —1,526 | filing |
| 29 Apr 2024filed 30 Apr 2024 | FLUX Flux Power HoldingsElectronic Components & EMS | SEC FORM 4 Sold | $2,403534 at $4.50 | filing |
| 22 Apr 2024filed 30 Apr 2024 | FLUX Flux Power HoldingsElectronic Components & EMS | SEC FORM 4 Sold | $24K5,909 at $4.03 | filing |
| 22 Apr 2024filed 22 Apr 2024 | FLUX Flux Power HoldingsElectronic Components & EMS | SEC FORM 4 Sold | $24K5,909 at $4.03 | filing |
| 20 Apr 2024filed 30 Apr 2024 | FLUX Flux Power Holdingsoption or derivative · Electronic Components & EMS | SEC FORM 4 Code M | —16,883 | filing |
| 20 Apr 2024filed 30 Apr 2024 | FLUX Flux Power HoldingsElectronic Components & EMS | SEC FORM 4 Code M | —16,883 | filing |
News
Supernus Pharmaceuticals (NASDAQ:SUPN) vs. Kiora Pharmaceuticals (NASDAQ:KPRX) Critical SurveyKPRX · tickerreport.com · 11 Oct 2026
0 headlines in the last 90 days name Lisa Walters-Hoffert; 1 article from the last 14 days about the 2 companies they traded most, at most three about any one of them.